Psychometric research and clinical screening: Do we really want one without the other?

Psycho-Oncology

Volumn 18, Issue 7, 2009, Pages 789-790

  Recklitis, Christopher J ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL ASSESSMENT; CLINICAL DECISION MAKING; CLINICAL EFFECTIVENESS; DISTRESS SYNDROME; EMOTIONAL STRESS; LETTER; MENTAL HEALTH; MENTAL HEALTH SERVICE; PATIENT REFERRAL; PSYCHOMETRY; PSYCHOSOCIAL CARE; SCREENING;

ANXIETY; DEPRESSION; FOLLOW-UP STUDIES; HEALTH SERVICES ACCESSIBILITY; HUMANS; MASS SCREENING; MENTAL HEALTH SERVICES; NEOPLASMS; PATIENT ACCEPTANCE OF HEALTH CARE; PERSONALITY INVENTORY; PSYCHOMETRICS; REFERRAL AND CONSULTATION; REPRODUCIBILITY OF RESULTS; RESEARCH;

EID: 67749113546     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.1474     Document Type: Letter

References (6)

1. Valenstein M, Vijan S, Zeber JE, Boehm K, Buttar A. The cost-utility of screening for depression in primary care. Ann Intern Med 2001; 134:345-360.
2. Pignone MP, Gaynes BN, Rushton JL et al. Screening or depression in adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002;136:765-776.
3. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: distress management. 2007. Available at: http://www.nccn.org/professionals/physician_gls/PDF/distress.pdf (accessed September 10, 2008).
4. United States Preventive Services Task Force. Screening for depression: recommendations and rationale. Ann Intern Med 2002; 136:760-764.
5. Morrison As. Screening in Chronic Disease (2nd edn). Oxford University Press: New York, 1992.
6. Unites States Preventive Services Task Force. Screening for prostate cancer: U.S. Preventative Services Task Force recommendation statement. Ann Intern Med 2008;149:185-191.